Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
6h
StudyFinds on MSNLake swimming in Iowa led to rare Legionnaires’ disease case that puzzled doctors for daysIn A Nutshell While Legionnaires’ disease typically makes headlines when linked to building water systems, this case shows that natural water sources like lakes can also harbor the bacteria, ...
Saroornagar police arrest key broker Laxman in illegal kidney trade; investigation ongoing into doctors, hospitals involved in 60 transplants ...
16h
CNET on MSN13 Foods Best for Fueling Kidney HealthWe all have them -- or at least one and need the kidney to survive. These vital organs serve as your body's way of getting ...
The new launches include a bonding line, a natural dry shampoo and a body wash with food-inspired ingredients.
About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...
Having itchy skin is usually nothing to worry about, but if it persists it could indicate something more serious.
7h
News Medical on MSNAmerican Heart Association launches preventive health initiative for CKM syndromeFive regions in the U.S. have been selected to implement a new preventive health initiative to improve care for people with a cluster of chronic conditions known as cardiovascular-kidney-metabolic ...
The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...
Obinutuzumab B-cell depleting therapy is more effective than standard care in treating patients with active proliferative lupus nephritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results